Fig. 2: Distant recurrence rate by chemotherapy regimen and ROR score.

Estimates of distant recurrence rate in patients in the CMF (a) and in the CEF (b) arm, according to Prosigna ROR ≤ 51, 52–71, and ≥72. 10-year estimates with 95% CI are included.